About Boston Harbor Angels
Boston Harbor Angels, established in 2004, is an angel investment group based in Boston, United States. It primarily focuses on Series A investments in companies in United States. Its portfolio includes 70 firms, spanning the Life Sciences, Enterprise Applications sectors. Its most notable investments include companies like Carbonite, Myomo and Pixability. As of Oct 2026, Boston Harbor Angels has witnessed 18 portfolio exits. Its latest investment was a $13M Seed round in GelMEDIX on Feb 17, 2026, which also saw participation from Safar Partners and HTL Biotechnology.
To date, 51 investors have co-invested in Boston Harbor Angels's portfolio companies, including prominent names like Launchpad Venture Group.
Key Metrics
Founded Year
2004
Location
Boston, United States
Sectors of Investment
Stages of Investment
Series A, Seed & 3 more
Locations of Investment
Boston Harbor Angels' List of Top Investments
Boston Harbor Angels has a portfolio of 70 companies. Their most notable investments are in Xeno Biosciences and TikaTok.Their portfolio spans across United States, Canada and Egypt. They have invested in Life Sciences, Enterprise Applications, HealthTech and 21 other sectors, across stages such as Series A, Seed and 3 more. Here is the list of top investments by Boston Harbor Angels:1. Carbonite
Carbonite provides cloud and hybrid business continuity solution to small and medium sized businesses. Its solutions include Carbonite Personal solution which offers cloud backup solutions for one computer, Carbonite Server Backup, a hybrid server backup solution that provides server backup for physical and virtual servers. It also provides monitoring and reporting solutions for the backup software.
Key facts about Carbonite
- Founded Year: 2005
- Location: Boston (United States)
- Annual Revenue: $100M - $500M as on Dec 31, 2018
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $66M
- Employee Count: 196 as on Aug 31, 2026
- Investors: ArrowMark Partners, Four Rivers Group and 19 Others
- Latest Funding Round: Conventional Debt, Feb 07, 2019, $*****
- Highlight: Acquired
2. Myomo
Provider of a robotic arm for mobility and rehabilitation. It is a medical device company focused on myoelectric prosthetic technology for powered braces (orthotics) that support weakened extremities. This technology helps individuals with neuromuscular conditions such as stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, multiple sclerosis, and ALS.
Key facts about Myomo
- Founded Year: 2004
- Location: Boston (United States)
- Annual Revenue: $10M - $50M as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $17.2M
- Employee Count: 134 as on Aug 31, 2026
- Investors: Empery Asset Management, Springboard Enterprises and 5 Others
- Latest Funding Round: Conventional Debt, Oct 23, 2019, $*****
- Highlight: Public
3. Pixability
Pixability offers a cloud-based video marketing solution for Youtube. It is a video marketing company offering ad performance measurement on Youtube. Its product PixabilityONE, a video advertising software platform that runs campaigns managed by Pixability and is also used by agencies and brands as a self-serve platform. Also offers a Youtube ad buying and video marketing platform for media professionals. Customers include Zipcar, Sharp, Puma, Loreal, Viacom, Gillette, Chanel, Swarovski, and more.
Key facts about Pixability
- Founded Year: 2008
- Location: Boston (United States)
- Stage: Series C
- Total Funding till date: $28.4M
- Employee Count: 110 as on Aug 31, 2026
- Investors: Progress Ventures, PJC and 14 Others
- Latest Funding Round: Series C, Apr 08, 2015, $*****
- Highlight: Editors' Pick
Astrocyte Pharmaceuticals is a small drug development company focussed on developing neuroprotection therapies for brain injury, concussions, stroke, and neurodegenerative disorders. It is developing its drugs that can activate astrocyte, a cell of the CNS that has the potential to treat CNS disorders such as brain injury, stroke, Alzheimer’s Disease.
Key facts about Astrocyte Pharmaceuticals
- Founded Year: 2014
- Location: Cambridge (United States)
- Stage: Series B
- Total Funding till date: $25.4M
- Employee Count: 12 as on Sep 30, 2026
- Investors: UT System, Dreavent and 18 Others
- Latest Funding Round: Series B, Sep 30, 2026, $*****
- Highlight: Editors' Pick
5. CleanFiber
Provider of cellulose insulation solutions for facilities. It is provided in the form of recycled cardboard. Its features include a proprietary wet separation and infusion process that floats off contaminants, abundant raw material for the production of insulating material, and an all-borate formulation used to make it fire-safe insulation.
Key facts about CleanFiber
- Founded Year: 2013
- Location: Buffalo (United States)
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $144M
- Employee Count: 56 as on Sep 30, 2026
- Investors: Clean Energy Ventures, Clean Energy Venture Group and 34 Others
- Latest Funding Round: Series C, Jun 22, 2026, $*****
- Highlight: Editors' Pick
Boston Harbor Angels' Year-on-Year Investment Trends
Boston Harbor Angels has invested in 70 companies over the last 19 years, with an average of 1 new investment annually in the last 10 years. As of Feb 2026, it has made 1 investment in this year. Its most recent first time investment was in GelMEDIX and most recent follow-on round was in Astrocyte Pharmaceuticals.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 0 | 1 |
2025 | 0 | 0 | 0 |
2024 | 0 | 0 | 0 |
2023 | 0 | 1 | 1 |
2022 | 0 | 1 | 1 |
2021 | 2 | 0 | 2 |
2020 | 0 | 1 | 1 |
2019 | 1 | 0 | 1 |
2018 | 0 | 0 | 0 |
2017 | 1 | 0 | 1 |
Boston Harbor Angels' Investments by Stage
Boston Harbor Angels has made 11 investments in Series A stage with an average round size of $2.38M, 7 investments in Seed stage with an average round size of $3.52M, 2 investments in Angel stage with an average round size of $1.06M, 1 investment in Series B stage with an average round size of $2.46M and 1 investment in Series D stage with an average round size of $4.1M.Stage of entry | No. of Investments |
|---|---|
Series A | 11 |
Seed | 7 |
Angel | 2 |
Series B | 1 |
Series D | 1 |
Note: We have considered here, only first round of investments
Boston Harbor Angels' Investments by Sector
Boston Harbor Angels has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, High Tech, Consumer and EdTech. Notably, it has invested in 52 Tech companies, 40 Enterprise (B2B) companies, 22 Software companies and at least 19 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Life Sciences | 11 |
Enterprise Applications | 7 |
High Tech | 4 |
Consumer | 3 |
EdTech | 2 |
Others | 10 |
Note: We have considered here, only first round of investments
Boston Harbor Angels' Investments by Geography
Boston Harbor Angels has made most investments in United States (21), followed by China where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 21 |
China | 1 |
Egypt | 1 |
Note: We have considered here, only first round of investments
Boston Harbor Angels' recent investments
Boston Harbor Angels has made 1 investments in 2026 so far - GelMEDIX.Here are the most recent investments by Boston Harbor Angels:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Feb 17, 2026 | United States | Seed | 9286 | [+3] | |
Aug 21, 2023 | United States | Series A | 8397 | [+6] | |
Jun 03, 2022 | United States | Series B | 9891 | [+4] | |
2021 | United States | Series A | 6753 | [+2] | |
Jan 27, 2021 | United States | Seed | 6732 | [+16] |
IPOs and Publicly Listed companies in Boston Harbor Angels' Portfolio
3 of Boston Harbor Angels' portfolio companies have become public. Myomo got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jun 2017 at marketcap of $53M and Corbus Pharma got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ).Here are Boston Harbor Angels' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jun 12, 2017 | - | - | 1686 | |
Nov 17, 2014 | - | - | 2586 | |
Apr 16, 2010 | - | - | 2325 |
Acquired companies in Boston Harbor Angels' Portfolio
15 companies from Boston Harbor Angels' portfolio have been acquired. The most recent acquisition was Plymouth Industrial REIT in Oct 2025 by Makarora for $*****.Here are Boston Harbor Angels' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 24, 2025 | - | - | 1176 | |
Feb 13, 2023 | Jan 27, 2021 | Seed | 3596 | |
Feb 02, 2021 | - | - | 6998 | |
Aug 19, 2020 | - | - | 6138 | |
Nov 11, 2019 | - | - | 8625 |
Co-investors of Boston Harbor Angels
Over the past 19 years, 109 investors have co-invested in Boston Harbor Angels's portfolio companies. This includes funds and angels.
- Invested before Boston Harbor Angels: HHS, Connecticut Innovations and 12 others have invested in rounds before Boston Harbor Angels. There are 5 companies where HHS has invested before Boston Harbor Angels and 2 companies where Connecticut Innovations has invested before Boston Harbor Angels.
- Top Co-investors of Boston Harbor Angels: 51 investors entered a company along with Boston Harbor Angels. These include investors like Launchpad Venture Group (9 companies).
- Invested after Boston Harbor Angels: A total of 44 investors have invested in Boston Harbor Angels's portfolio after their investments. Top Investors include NIH (4 companies) and HHS (3 companies).
Recent News related to Boston Harbor Angels
•
GelMEDIX Raises $13M in Seed FundingFinSMEs•Feb 17, 2026•GelMEDIX, TiE Boston, HTL Biotechnology, Safar Partners and 2 others
•
•
Zylö Therapeutics Closes $5.225 Million Series B FinancingGlobeNewswire•Jun 03, 2022•Zyl Therapeutics, VentureSouth, SCRA, New York Angels and 2 others
•
•
Zylö Therapeutics Raises $4M in Series A FinancingFinSMEs•Sep 26, 2019•Zyl Therapeutics, VentureSouth, New York Angels, Ariel Southeast Angel Partners and 2 others
•
•
Connecticut Innovations Invests $330k in BIOARRAY TherapeuticsConnecticut Innovations•May 07, 2015•Bioarray, Connecticut Innovations, Angel Investor Forum, Boston Harbor Angels
•
Founder Update: BIOARRAY Secures Series A Funding | VDCUniversity of Massachusetts Boston•Apr 29, 2015•Bioarray, Connecticut Innovations, Angel Investor Forum, Boston Harbor Angels
•
Device startup raises $2M to build iPod-sized wearable that uses ultrasound for painMedCity News•Jun 26, 2014•ZetrOZ, Connecticut Innovations, Angel Investor Forum, Mass Medical Angels and 2 others
•
Sialix closes series B - PE HubPE Hub•Feb 06, 2014•Siamab, Mass Medical Angels, Launchpad Venture Group, Maine Angels and 3 others